XML 99 R73.htm IDEA: XBRL DOCUMENT
v3.24.0.1

INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details) $ in Millions | 1 Months Ended | 10 Months Ended | 12 Months Ended |
--- | --- | --- | --- | ---
Mar. 31, 2023 USD ($) | Aug. 31, 2022 USD ($) | Jun. 30, 2022 USD ($) | May 31, 2022 USD ($) note | Dec. 31, 2023 USD ($) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2019 USD ($) | Apr. 30, 2021 USD ($)
Variable Interest Entity [Line Items] |  |  |  |  |  |  |  |  |  |
Payment for acquisition options |  |  |  |  |  | $ 30.0 | $ 109.6 | $ 13.1 |  |
Number of promissory notes entered | note |  |  |  | 2 |  |  |  |  |  |
Maximum secured promissory note |  |  |  |  |  |  |  |  |  | $ 45.0
Investee drew additional amount |  |  |  |  | $ 30.0 | 30.0 |  |  |  |
Carrying value of non-marketable equity securities |  |  |  |  | 87.6 | 87.6 | $ 86.9 | 39.3 |  |
Investment option to acquire |  |  |  |  |  |  |  | 13.1 |  |
Maximum additional required investment |  |  |  |  |  |  |  | 6.5 |  |
Maximum additional option to acquire investment |  |  |  |  |  |  |  | 14.4 |  |
Medical Device Company | Variable Interest Entity, Not Primary Beneficiary |  |  |  |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |  |  |  |
Loans receivables, maximum lending amount | $ 45.0 |  | $ 47.5 |  |  |  |  |  |  |
Payment for acquisition options |  | $ 47.1 |  |  | 30.0 |  |  |  | $ 35.0 |
Financing receivable |  |  |  |  | 32.5 | 32.5 |  |  |  |
Option to acquire investment amount |  | $ 47.1 |  |  | 35.0 | 35.0 |  |  |  |
Maximum secured promissory note |  |  |  | $ 25.0 |  |  |  |  |  |
Medical Device Company | Variable Interest Entity, Not Primary Beneficiary | Convertible Promissory Note |  |  |  |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |  |  |  |
Financing receivable | $ 5.0 |  |  |  |  |  |  |  |  |
Medical Technology Company | Variable Interest Entity, Not Primary Beneficiary |  |  |  |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |  |  |  |
Payment for acquisition options |  |  |  | 60.0 |  |  |  | $ 10.0 |  |
Option to acquire investment amount |  |  |  | $ 60.0 |  |  |  |  |  |
Maximum secured promissory note |  |  |  |  | $ 25.0 | $ 25.0 |  |  |  |

X
- Definition Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment + References No definition available. + Details
Name: | ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Equity Securities, FV-NI, Maximum Additional Required + References No definition available. + Details
Name: | ew_EquitySecuritiesFVNIMaximumAdditionalRequired
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Equity Securities, FV-NI, Maximum Promissory Note + References No definition available. + Details
Name: | ew_EquitySecuritiesFVNIMaximumPromissoryNote
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Equity Securities, FV-NI, Maximum Secured Promissory Note + References No definition available. + Details
Name: | ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Equity Securities, FV-NI, Option To Acquire Investment + References No definition available. + Details
Name: | ew_EquitySecuritiesFVNIOptionToAcquireInvestment
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Equity Securities, FV-NI Promissory Note Outstanding + References No definition available. + Details
Name: | ew_EquitySecuritiesFVNIPromissoryNoteOutstanding
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Loans Receivables, Maximum Lending Capacity + References No definition available. + Details
Name: | ew_LoansReceivablesMaximumLendingCapacity
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number Of Promissory Notes Entered + References No definition available. + Details
Name: | ew_NumberOfPromissoryNotesEntered
Namespace Prefix: | ew_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Option To Acquire Investment, Amount + References No definition available. + Details
Name: | ew_OptionToAcquireInvestmentAmount
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Publisher FASB -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A + Details
Name: | us-gaap_EquitySecuritiesFvNi
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 80 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479294/326-20-55-80 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 79 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479294/326-20-55-79 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(3)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-K (SK) -Number 229 -Section 1405 -Paragraph (a) -Subparagraph (1) -Publisher SEC Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-K (SK) -Number 229 -Section 1405 -Paragraph (a) -Subparagraph (2) -Publisher SEC Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-K (SK) -Number 229 -Section 1404 -Paragraph (a) -Publisher SEC Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479319/326-20-50-14 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 7A -SubTopic 10 -Topic 310 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481962/310-10-50-7A Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479319/326-20-50-5 + Details
Name: | us-gaap_NotesReceivableGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_OtherPaymentsToAcquireBusinesses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (bb) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 860 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (b)(1)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 860 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (b)(1)(ii) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 860 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A + Details
Name: | us-gaap_VariableInterestEntityLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=ew_MedicalDeviceCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=ew_ConvertiblePromissoryNoteMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ew_MedicalTechnologyCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |